Precigen (PGEN) Non Operating Investment Income (2015 - 2016)
Precigen (PGEN) reported Non Operating Investment Income of -$22.3 million for Q1 2016, down 119.34% year-over-year from $115.5 million in Q2 2015, and down 119.34% quarter-over-quarter from $115.5 million in Q1 2015.
Precigen (PGEN) Non Operating Investment Income (2015 - 2016) Analysis & Trends
Precigen (PGEN) has 2 years of Non Operating Investment Income data on file, last reported at -$22.3 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 230,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Precigen | 1.38 Bn | 1.38 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | -22.33 Mn |
| Mar 31, 2016 | -22.33 Mn |
| Mar 31, 2015 | 115.45 Mn |
| Mar 31, 2015 | 115.45 Mn |